- Within3 — the leading enterprise-wide solution for life science collaboration and communication — announced it has closed over $100 million in growth funding
Within3 — the leading enterprise-wide solution for life science collaboration and communication — announced it has closed over $100 million in growth funding in a financing round led by Insight Partners with participation from Silversmith Capital Partners. And the funding will be used to accelerate product innovation, build infrastructure to outpace growing demand, and fuel international expansion.
Currently, 20 out of the top 20 pharmaceutical companies already use Within3 for global collaboration to bring drugs to market more quickly, publish clinical studies, host advisory boards, and engage virtually on business initiatives with multi-stakeholder involvement. And with users in over 150 countries and thousands of implementations worldwide, Within3 is the pioneer in enabling complex virtual communication in a secure environment.
Each implementation is carefully designed for driving business outcomes and allows asynchronous participation supplemented with real-time touchpoints. And always-available reporting and analytics ensure real-time alignment of program goals. Within3’s unique combination of real-time and over-time communication drive the highest level of engagement and strong and measurable business results across the enterprise.
With more than 80 compliance features, translation into over 100 languages and a world-class client success team that is a part of every single implementation, life science companies are turning to Within3 as an enterprise-wide solution and their primary resource for stakeholder engagement.
Aeris Partners LLC served as the exclusive financial advisor to Within3. And Willkie Farr & Gallagher served as legal advisors to Insight and Kirkland and Ellis represented Silversmith Capital Partners.
KEY QUOTES:
“Global demand for our solution is surging at an unprecedented rate. Life science companies are looking for virtual work solutions that exceed the level of engagement of traditional live interactions, meet all their compliance needs, and that will scale across the enterprise. They have found that solution with Within3.”
“The funding will allow us to accelerate our growth and product pipeline to continue to meet the growing demand from the market. We will be able to accelerate new innovations in our product roadmap and bring our customers smarter, more innovative solutions faster.”
— Lance Hill, CEO of Within3
“Investment opportunities in companies like Within3 don’t come around very often. The company has seen explosive growth over the last 12 quarters and continues to break new records each month. Their unparalleled ability to enable companies to achieve the results they desire faster and cheaper, and scale across the enterprise solving complex problems in all divisions of an organization sets them apart from other virtual engagement solutions. At a time when collaboration, communication and cooperation are more critical than ever across the global life sciences ecosystem, we are excited to bring our strategic operations expertise to help Within3 scale.”
— Deven Parekh, Managing Director at Insight Partners
Parekh, along with Insight Partners’ Managing Directors Adam Berger and Ross Devor will join Within3’s board.
